Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54
Published December 5, 2012 · Recall initiated: November 5, 2012
Summary
FDA records drug Class II recall D-067-2013, published December 5, 2012 and initiated November 5, 2012. Recalling firm: Boehringer Ingelheim Roxane Inc; Status: Terminated; Reported quantity: 8,381 bottles; Lot: Lot 201900 Expiration Date: JAN 2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boehringer Ingelheim Roxane Inc
- Distributor
- Nationwide
- Lot
- Lot 201900 Expiration Date: JAN 2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, RoxaneAugust 6, 2014
- FDACalcitriol Oral Solution 1 mcg/mL, 15mL bottle, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDCJuly 16, 2014
- FDAMercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio,May 14, 2014
- FDAAzathioprine Tablets USP, 50 mg, 100 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216,May 14, 2014
- FDAMylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505December 5, 2012
- FDAArranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, ResearchDecember 5, 2012
Questions about this recall
Was Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54 recalled?
Yes. FDA published recall D-067-2013 on December 5, 2012. Reported hazard: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
What should I do if I have this product?
Voluntary: Firm initiated · Letter